Active targeting behaviors of biotinylated Pluronic/poly (lactic acid) nanoparticles in vitro through three-step biotin-avidin interaction

Journal of Biomaterials Science, Polymer Edition

Volumn 22, Issue 12, 2011, Pages 1607-1619

  Xiong, Xiang Yuan ^a   Gong, Yan Chun ^a   Li, Zi Ling ^a   Li, Yu Ping ^a   Guo, Liang ^a  

^a JIANGXI SCIENCE AND TECHNOLOGY NORMAL UNIVERSITY   (China)

Author keywords

biotin pluronic poly(lactic acid); Co polymer; nanoparticles; paclitaxel; targeted drug delivery

Indexed keywords

ANTIGENS; CELLS; COENZYMES; CONTROLLED DRUG DELIVERY; CYTOLOGY; FLUORESCENCE MICROSCOPY; GLYCOPROTEINS; LACTIC ACID; NANOPARTICLES;

ACTIVE TARGETING; BIOTIN-AVIDIN; CYTOTOXICITY TEST; OVARIAN CANCER CELLS; PACLITAXEL; POLY LACTIC ACID; RELEASE BEHAVIORS; SPECIFIC INTERACTION;

TARGETED DRUG DELIVERY;

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; AVIDIN; BIOTIN; CA 125 ANTIGEN; NANOPARTICLE; PACLITAXEL; POLOXAMER; POLYLACTIC ACID;

ARTICLE; BIOTINYLATION; CANCER CELL; CANCER THERAPY; CHEMICAL INTERACTION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG TARGETING; FLUORESCENCE MICROSCOPY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; OVARY CANCER; PRIORITY JOURNAL;

EID: 79957792708     PISSN: 09205063     EISSN: 15685624     Source Type: Journal    
DOI: 10.1163/092050610X519444     Document Type: Article

References (30)

1. M. Prabaharan, J. J. Grailer, S. Pilla, D. A. Steeber and S. Q. Gong, Biomaterials 30, 3009 (2009).
2. O. Onaca, R. Enea, D. W. Hughes and W. Meier, Macromol. Biosci. 9, 129 (2009).
3. Y. B. Patil, U. S. Toti, A. Khdair, L. Ma and J. Panyam, Biomaterials 30, 859 (2009).
4. Z. P. Zhang, S. H. Lee, C. W. Gan and S. S. Feng, Pharm. Res. 25, 1925 (2008).
5. J. Pan and S. S. Feng, Biomaterials 29, 2663 (2008).
6. E. Q. Song, Z. L. Zhang, Q. Y. Luo,W. Lu, Y. B. Shi and D.W. Pang, Clin. Chem. 55, 955 (2009).
7. X. Han, J. Liu, M. Liu, C. Xie, C. Y. Zhan, B. Gu, Y. Liu, L. L. Feng and W. Y. Lu, Int. J. Pharm. 372, 125 (2009).
8. Z. Y. Hu, F. Luo, Y. F. Pan, C. Hou, L. F. Ren, J. J. Chen, J. W. Wang and Y. D. Zhang, J. Biomed. Mater. Res. A 85, 797 (2008).
9. S. Chen, X. Z. Zhang, S. X. Cheng, R. X. Zhuo and Z.W. Gu, Biomacromolecules 9, 2578 (2008).
10. R. Gref, P. Couvreur, G. Barratt and E. Mysiakine, Biomaterials 24, 4529 (2003).
11. M. Pulkkinen, J. Pikkarainen, T. Wirth, T. Tarvainen, V. Haapa-Acho, H. Korhonen, J. Seppala and K. Jarvinen, Eur. J. Pharm. Biopharm. 70, 66 (2008).
12. C. Cheng, H.Wei, B. X. Shi, H. Cheng, C. Li, Z.W. Gu, S. X. Cheng, X. Z. Zhang and R. X. Zhuo, Biomaterials 29, 497 (2008).
13. Z. Xiao, S. A. McQuarrie, M. R. Suresh, J. R. Mercer, S. Gupta and G. G. Miller, J. Biotechnol. 94, 171 (2002).
14. J. R. Newton-Northup, S. D. Figueroa, T. P. Quinn and S. L. Deutscher, Nucl. Med. Biol. 36, 789 (2009).
15. P. Macor, C. Tripodo, S. Zorzet, E. Piovan, F. Bossi, R. Marzari, A. Amadori and F. Tedesco, Cancer Res. 67, 10556 (2007).
16. N. Cauchon, R. Langlois, J. A. Rousseau, G. Tessier, J. Cadorette, R. Lecomte, D. J. Hunting, R. A. Pavan, S. K. Zeisler and J. E. van Lier, Eur. J. Nucl. Med. Mol. I 34, 247 (2007).
17. S. J. Knox, M. L. Goris, M. Tempero, P. L.Weiden, L. Gentner, H. Breitz, G. P. Adams, D. Axworthy, S. Gaffigan, K. Bryan, D. R. Fisher, D. Colcher, I. D. Horak and L. M. Weiner, Clin. Cancer Res. 6, 406 (2000).
18. C. Grana, M. Bartolomei, D. Handkiewicz, P. Rocca, L. Bodei, N. Colombo, M. Chinol, C. Mangioni, F. Malavasi and G. Paganelli, Gynecol. Oncol. 93, 691 (2004).
19. P. Caliceti, M. Chinol, M. Roldo, F. M. Veronese, A. Semenzato, S. Salmaso and G. Paganelli, J. Control. Rel. 83, 97 (2002).
20. Z. L. Li, X. Y. Xiong, Y. P. Li, Y. C. Gong, X. X. Gui, X. Ou-Yang, H. S. Lin, L. J. Zhu and J. L. Xie, J. Appl. Polym. Sci. 115, 1573 (2010).
21. A. K. Salem, S. M. Cannizzaro, M. C. Davies, S. J. B. Tendler, C. J. Roberts, P. M. Williams and K. M. Shakesheff, Biomacromolecules 2, 575 (2001).
22. S. M. Cannizzaro, R. F. Padera, R. Langer, R. A. Rogers, F. E. Black, M. C. Davies, S. J. B. Tendler and K. M. Shakesheff, Biotechnol. Bioeng. 58, 529 (1998).
23. A. V. Kabanov, E. V. Batrakova and V. Y. Alakhov, Adv. Drug Deliv. Rev. 54, 759 (2002).
24. H.-K. Nguyen, P. Lemieux, S. V. Vinogradov, C. L. Gebhart, N. Guérin, G. Paradis, K. T. Bronich, V. Y. Alakhov and A. V. Kabanov, Gene Ther. 7, 126 (2000).
25. L. B. Luo, J. Tam, D. Maysinger and A. Eisenberg, Bioconjug. Chem. 13, 1259 (2002).
26. L. Y. Lee, C. H. Wang and K. A. Smith, J. Control. Rel. 125, 96 (2008).
27. G. S. He, L. L. Ma, J. Pan and S. Venkatraman, Int. J. Pharm. 334, 48 (2007).
28. G. Ruan and S. S. Feng, Biomaterials 24, 5037 (2003).
29. F. Ahmed and D. E. Discher, J. Control. Rel. 96, 37 (2004).
30. R. Savic, L. B. Luo, A. Eisenberg and D. Maysinger, Science 300, 615 (2003).